Skip to main content

Closed

OBIO: Orchestra BioMed Holdings, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-168.0%

ROIC-62.6%

Financially safe

Stretched

Debt / equity0.66×

Interest coverage-26.2×

Current ratio7.03×

Orchestra BioMed Holdings, Inc.

OBIONASDAQ Global Market·USD·Closed

Orchestra BioMed Holdings, Inc.

OBIONASDAQ·USD·Closed

$3.98

−0.25%

$3.98

−$0.01 (0.25%)

52W Range

55thpctl

Volume

0.47×avg

Mkt Cap

238.33MUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

55thpctl

Volume

0.47×avg

Market Cap

238.33MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings